Form 4 for LH Labcorp
Accepted 2024-04-03 00:00:00 ET · period of report 2024-04-01 · accession 0001127602-24-012006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-03 | 2024-04-01 | LH | Schroeder Mark S | EVP, COO, Pres Diagnostics | S - Sale | $217.29 | -6,477 | 5,036 | -56% | -$1.41M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-01 | S | D | 6,477 | $217.29 | 5,036.14 | D | — | — |